A prospective multicenter series study for immunological indexes in the treatment of patients with periprosthetic infection

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900024234

Enrollment

Unknown

Registered

2019-07-01

Start date

2019-06-27

Completion date

Unknown

Last updated

2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

periprosthetic infection

Interventions

PJI group:none

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Meet the (MSIS) diagnostic criteria of periprosthetic infection; aged 18 to 70 years old; informed consent

Exclusion criteria

Exclusion criteria: Pregnant or lactating women; those who are using immunosuppressants or immunoenhancers.

Design outcomes

Primary

Measure	Time frame
Humoral immunity index;Complete set of lymphocyte subsets;Infection control rate;	—

Secondary

Measure	Time frame
Blood routine;Biochemistry;CRP;ESR;	—

Countries

China

Contacts

Public ContactWei Chai

Chinese PLA General Hospital

chaiweiguanjie@sina.com+86 010 66938404

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026